Lithium citrate

This classification denotes an antipsychotic agent with the molecular formula C6H5O7.3Li.4H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5Z6E9K79YV, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, trilithium salt but generally known as lithium citrate, which bears US NIH Compound Identifier 13520. European Medicines Agency schedules Lithium citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14377MIG. Most nations schedule lithium citrate under HS 29181590 and SITC 51391. As of Q4 2014, LITHIUM CITRATE remains the US FDA Preferred Term for this commodity. Lithium citrate bears US NLM identifiers UMLS ID C0125997 and NCI Concept Code C61812. SMILES: OC(CC(=O)O)(CC(=O)O)C(=O)O.[LI].[LI].[LI].